Gujarat Themis Biosyn Limited

Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.

Summary as recorded on Fri, 04 Sept, 2026.

• Financial Results/Other business mattersSat, 14 Nov, 2026

Historical quarterly results aren't available in the current data feed.

No recent corporate actions for GUJTHEM.